Company registration number 02365029 (England and Wales)
EDGBASTON MEDICAL GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023
PAGES FOR FILING WITH REGISTRAR
EDGBASTON MEDICAL GROUP LIMITED
COMPANY INFORMATION
Director
M Lester
(Appointed 1 September 2023)
Company number
02365029
Registered office
71-75
Shelton Street
London
WC2H 9JQ
Accountants
Jerroms GCN Limited
West Point, Second Floor
Mucklow Office Park
Mucklow Hill
Halesowen
B62 8DY
EDGBASTON MEDICAL GROUP LIMITED
CONTENTS
Page
Accountants' report
1
Statement of financial position
2 - 3
Notes to the financial statements
4
EDGBASTON MEDICAL GROUP LIMITED
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ACCOUNTS OF EDGBASTON MEDICAL GROUP LIMITED
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Edgbaston Medical Group Limited for the year ended 30 November 2023 which comprise, the statement of financial position and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/gb/en/member/standards/rules-and-standards/rulebook.html.

This report is made solely to the board of directors of Edgbaston Medical Group Limited, as a body, in accordance with the terms of our engagement letter dated 31 August 2023. Our work has been undertaken solely to prepare for your approval the financial statements of Edgbaston Medical Group Limited and state those matters that we have agreed to state to the board of directors of Edgbaston Medical Group Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Edgbaston Medical Group Limited and its board of directors as a body for our work or for this report.

It is your duty to ensure that Edgbaston Medical Group Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and result of Edgbaston Medical Group Limited. You consider that Edgbaston Medical Group Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Edgbaston Medical Group Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Jerroms GCN Limited
27 August 2024
Chartered Certified Accountants
West Point, Second Floor
Mucklow Office Park
Mucklow Hill
Halesowen
B62 8DY
EDGBASTON MEDICAL GROUP LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
30 NOVEMBER 2023
30 November 2023
- 2 -
2023
2022
Notes
£
£
£
£
Current assets
-
-
Creditors: amounts falling due within one year
3
(884,238)
(884,238)
Net current liabilities
(884,238)
(884,238)
Capital and reserves
Called up share capital
4
1,102
1,102
Profit and loss reserves
(885,340)
(885,340)
Total equity
(884,238)
(884,238)
EDGBASTON MEDICAL GROUP LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
30 NOVEMBER 2023
30 November 2023
- 3 -

The director of the company has elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 27 August 2024 and are signed on its behalf by:
M Lester
Director
Company Registration No. 02365029
EDGBASTON MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023
- 4 -
1
Accounting policies
Company information

Edgbaston Medical Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is 71-75, Shelton Street, London, WC2H 9JQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The accounts have been prepared on the going concern basis on the understanding that the director will continue to support the business for the foreseeable future.true

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
-
0
-
0
3
Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
884,238
884,238
4
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
1,102
1,102
1,102
1,102
2023-11-302022-12-01false27 August 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityD RossM Lesterfalsefalse023650292022-12-012023-11-3002365029bus:Director22022-12-012023-11-3002365029bus:Director12022-12-012023-11-3002365029bus:RegisteredOffice2022-12-012023-11-30023650292023-11-3002365029core:CurrentFinancialInstrumentscore:WithinOneYear2023-11-3002365029core:CurrentFinancialInstrumentscore:WithinOneYear2022-11-30023650292022-11-3002365029core:ShareCapital2023-11-3002365029core:ShareCapital2022-11-3002365029core:RetainedEarningsAccumulatedLosses2023-11-3002365029core:RetainedEarningsAccumulatedLosses2022-11-30023650292021-12-012022-11-3002365029core:CurrentFinancialInstruments2023-11-3002365029core:CurrentFinancialInstruments2022-11-3002365029bus:PrivateLimitedCompanyLtd2022-12-012023-11-3002365029bus:SmallCompaniesRegimeForAccounts2022-12-012023-11-3002365029bus:FRS1022022-12-012023-11-3002365029bus:AuditExemptWithAccountantsReport2022-12-012023-11-3002365029bus:FullAccounts2022-12-012023-11-30xbrli:purexbrli:sharesiso4217:GBP